Screener
Novavax NVAX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 38,133 | 44,800 |
| Right-of-use asset, net | 19,842 | 22,897 |
| Goodwill | 112,542 | 113,462 |
| Other non-current assets | 13,960 | 17,077 |
| Total assets | $955,575 | $1,176,512 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $22,936 | $24,578 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's deferred tax assets and other non-current assets?
- Novavax (NVAX) reported deferred tax assets and other non-current assets of $13.96M in Q2 2026.
- How has Novavax's deferred tax assets and other non-current assets changed year-over-year?
- Novavax's deferred tax assets and other non-current assets decreased by 34.7% year-over-year, from $21.39M to $13.96M.
- What is the long-term trend for Novavax's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Novavax's deferred tax assets and other non-current assets has grown at a 5.3% compound annual growth rate (CAGR), from $13.22M to $17.08M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Novavax's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude